Narrative Update • Jun 26
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 08, 2026
DataAggregated Company Financials
Companies7
- 7D-2.5%
- 3M2.5%
- 1Y-14.8%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has risen 2.5%, driven by gains from IXICO of 9.6%. However, the industry is down 10% over the past year. As for the next few years, earnings are expected to grow by 57% per annum.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 08 Jul 2026 | UK£1.4b | UK£323.1m | -UK£164,731,254.00 | 1274.4x | -8.4x | 4.3x |
| Fri, 05 Jun 2026 | UK£1.6b | UK£323.0m | -UK£166,018,254.00 | 1257x | -9.6x | 4.9x |
| Sun, 03 May 2026 | UK£1.4b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.2x | 4.3x |
| Tue, 31 Mar 2026 | UK£1.2b | UK£324.0m | -UK£161,423,254.00 | 8x | -7.7x | 3.9x |
| Thu, 26 Feb 2026 | UK£1.5b | UK£304.7m | -UK£159,511,254.00 | 11x | -9.6x | 5x |
| Sat, 24 Jan 2026 | UK£1.9b | UK£304.6m | -UK£159,441,254.00 | 7.5x | -11.8x | 6.2x |
| Mon, 22 Dec 2025 | UK£1.4b | UK£304.6m | -UK£159,441,254.00 | 9.5x | -8.9x | 4.7x |
| Wed, 19 Nov 2025 | UK£1.4b | UK£304.3m | -UK£163,156,254.00 | 7.8x | -8.7x | 4.7x |
| Fri, 17 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 9.2x | -9.8x | 5.3x |
| Sun, 14 Sep 2025 | UK£1.8b | UK£313.5m | -UK£158,190,352.00 | 6.2x | -11.4x | 5.8x |
| Tue, 12 Aug 2025 | UK£2.2b | UK£291.9m | -UK£160,968,352.00 | 7x | -13.9x | 7.7x |
| Thu, 10 Jul 2025 | UK£1.6b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -9.9x | 5.5x |
| Sat, 07 Jun 2025 | UK£1.6b | UK£319.4m | -UK£190,824,326.20 | 7x | -8.1x | 4.9x |
| Mon, 05 May 2025 | UK£1.7b | UK£314.0m | -UK£192,459,514.70 | 11.3x | -8.7x | 5.3x |
| Wed, 02 Apr 2025 | UK£1.4b | UK£315.8m | -UK£186,520,869.25 | 5.1x | -7.6x | 4.5x |
| Fri, 28 Feb 2025 | UK£1.6b | UK£306.4m | -UK£195,145,119.84 | 6.1x | -8.2x | 5.2x |
| Sun, 26 Jan 2025 | UK£2.0b | UK£306.8m | -UK£195,467,101.20 | 7.6x | -10.5x | 6.7x |
| Tue, 24 Dec 2024 | UK£1.8b | UK£306.7m | -UK£195,369,184.56 | 7.7x | -9.5x | 6x |
| Thu, 21 Nov 2024 | UK£1.7b | UK£306.4m | -UK£192,889,879.28 | 8.6x | -9x | 5.6x |
| Sat, 19 Oct 2024 | UK£2.0b | UK£304.5m | -UK£192,394,470.10 | 11.2x | -10.4x | 6.5x |
| Mon, 16 Sep 2024 | UK£2.0b | UK£301.9m | -UK£190,970,145.50 | 11x | -10.6x | 6.7x |
| Wed, 14 Aug 2024 | UK£1.8b | UK£296.5m | -UK£188,935,515.90 | 12.3x | -9.7x | 6.2x |
| Fri, 12 Jul 2024 | UK£1.6b | UK£295.3m | -UK£189,720,495.51 | 11.5x | -8.6x | 5.5x |
| Sun, 09 Jun 2024 | UK£1.6b | UK£295.7m | -UK£189,861,210.03 | 11.4x | -8.4x | 5.4x |
| Tue, 07 May 2024 | UK£1.6b | UK£292.7m | -UK£188,833,005.83 | 6902.8x | -8.3x | 5.3x |
| Thu, 04 Apr 2024 | UK£1.7b | UK£319.0m | -UK£191,330,284.65 | 71x | -8.9x | 5.3x |
| Sat, 02 Mar 2024 | UK£1.8b | UK£285.8m | -UK£189,240,511.01 | 6609.8x | -9.6x | 6.3x |
| Mon, 29 Jan 2024 | UK£2.7b | UK£450.2m | -UK£176,590,140.00 | 65.1x | -15.3x | 6x |
| Wed, 27 Dec 2023 | UK£3.1b | UK£450.0m | -UK£174,048,242.00 | 52.7x | -18.1x | 7x |
| Fri, 24 Nov 2023 | UK£3.0b | UK£455.6m | -UK£168,685,162.00 | 49.9x | -17.6x | 6.5x |
| Sun, 22 Oct 2023 | UK£3.1b | UK£458.7m | -UK£165,641,089.00 | 48.3x | -18.5x | 6.7x |
| Tue, 19 Sep 2023 | UK£3.1b | UK£440.7m | -UK£167,140,516.00 | 66.8x | -18.5x | 7x |
| Thu, 17 Aug 2023 | UK£3.1b | UK£476.1m | -UK£126,461,303.00 | 70.6x | -24.8x | 6.6x |
| Sat, 15 Jul 2023 | UK£3.0b | UK£475.6m | -UK£124,033,158.00 | 65.2x | -24.4x | 6.4x |
Price to Earnings Ratio
-24.4x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.4x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 1.55% | |
| Healthcare | 2.04% | |
| Life Sciences | -2.47% | |
| Clinical Research and Equipment | -2.47% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| IXI IXICO | UK£0.091 | 9.6% +UK£1.7m | -6.7% | PS2.7x | |
| HVO hVIVO | UK£0.07 | 2.9% +UK£1.4m | -31.7% | PS1x | |
| FAB Fusion Antibodies | UK£0.12 | 4.5% +UK£625.1k | 84.0% | PS9x | |
| OBD Oxford BioDynamics | UK£0.001 | 5.0% +UK£214.5k | -58.8% | PS3.8x |